Nuveen S&P 500 Buy-Writeome Fund's revenue for the
six
months ended in Dec. 2025 was $170.8 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $209.9 Mil.
Nuveen S&P 500 Buy-Writeome Fund's Revenue per Share for the
six
months ended in Dec. 2025 was $1.63.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $2.01.
Warning Sign:
Nuveen S&P 500 Buy-Write Income Fund revenue per share is in decline over the past 12 months.
During the past 9 years, Nuveen S&P 500 Buy-Writeome Fund's highest 3-Year average Revenue per Share Growth Rate was 34.20% per year. The lowest was -18.20% per year. And the median was -2.60% per year.
Nuveen S&P 500 Buy-Writeome Fund (NYSE:BXMX) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Nuveen S&P 500 Buy-Writeome Fund Revenue Related Terms
Nuveen S&P 500 Buy-Writeome Fund Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Nuveen S&P 500 Buy-Writeome Fund's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nuveen S&P 500 Buy-Writeome Fund Revenue vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Nuveen S&P 500 Buy-Writeome Fund's Revenue distribution charts can be found below:
* The bar in red indicates where Nuveen S&P 500 Buy-Writeome Fund's Revenue falls into.
Nuveen S&P 500 Buy-Writeome Fund Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $209.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nuveen S&P 500 Buy-Writeome Fund (BXMX) has a Revenue of $209.9 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Nuveen S&P 500 Buy-Writeome Fund and its competitors.
Is Nuveen S&P 500 Buy-Writeome Fund's Revenue too high?
Nuveen S&P 500 Buy-Writeome Fund's current Revenue is $209.9 Mil. Overall, Nuveen S&P 500 Buy-Writeome Fund has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Nuveen S&P 500 Buy-Writeome Fund's Revenue compare to CET and GAM?
Nuveen S&P 500 Buy-Writeome Fund's Revenue of $209.9 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for an Asset Management company?
A good Revenue depends on the Asset Management industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Nuveen S&P 500 Buy-Writeome Fund and its competitors. Nuveen S&P 500 Buy-Writeome Fund's current Revenue is $209.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuveen S&P 500 Buy-Writeome Fund stock overvalued right now?
Nuveen S&P 500 Buy-Writeome Fund (BXMX) has a current Revenue of $209.9 Mil. The stock's GF Value™ is $12.90, compared to a current price of $15.03 — trading 16.5% above its estimated fair value. The current Revenue is $209.9 Mil. Nuveen S&P 500 Buy-Writeome Fund's overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Nuveen S&P 500 Buy-Writeome Fund (BXMX), the current Revenue is $209.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nuveen S&P 500 Buy-Writeome Fund (BXMX) Overvalued in 2026?
Based on GuruFocus' analysis, Nuveen S&P 500 Buy-Writeome Fund stock appears to be overvalued.
The current stock price of $15.03 is trading 16.5% above its estimated GF Value™ of $12.90.
Key valuation signals for BXMX:
Revenue: $209.9 Mil
GF Value™: $12.90 vs. price of $15.03 (16.5% above fair value)
No single metric tells the full story. See the BXMX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nuveen S&P 500 Buy-Writeome Fund Business Description
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.
34GF Score
Get the complete analysis for BXMX
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BXMX has been successfully added to your 
